Endo pain drug linked with blood disorder when abused; Novartis drops long-acting Fanapt;

@FiercePharma: How is the U.K.'s fund for NICE-nixed cancer drugs faring? Total spent since 10/2010: £180.9M on 18K+ patients. Report | Follow @FiercePharma

> Endo Pharmaceuticals' ($ENDP) painkiller Opana can trigger a potentially fatal blood disorder if crushed and injected, one common method of pain-drug abuse. Report

> Novartis ($NVS) dropped development of a long-acting version of the antipsychotic drug Fanapt, after sales of the original version failed to live up to initial enthusiasm. Report

> Boehringer Ingelheim's clot-dissolving drug Actilyse got a boost from U.K. cost-effectiveness watchdogs, who broadened the potential treatment window for stroke patients. Report

> A drug shortage led to a tenfold increase in IV-related infections in hospitalized children, a study found. Report

> Teva Pharmaceutical Industries ($TEVA) supplier Venus Remedies is expected to see increased growth as resistant germs spur depand for its antibiotic combo drugs. Report

Biotech News

 @FierceBiotech: Alzheimer's drug builds new brain cell connections in rats. Story | Follow @FierceBiotech

 @JohnCFierce: New FDA lung cancer OK for Celgene's Abraxane should boost sales. More | Follow @JohnCFierce

 @RyanMFierce: Biotech regulars should appreciate this: Actress Jennifer Aniston investing in a Bob Langer company. More | Follow @RyanMFierce

> Intercept Pharma, Kythera Bio jump out of the IPO gate. Story

> NPS Pharma shares jump on upbeat FDA review of Gattex. News

> Vertex's new data on CF drug cocktail doesn't disappoint. Report

 @FierceMedDev: Coming soon: we'll find out if Intuitive Surgical's earnings slowed in Q3 as predicted. Let the speculation begin. More | Follow @FierceMedDev

 @MarkHFierce: Medtech industry's efficiency reaches new level, PwC report concludes. Article | Follow @MarkHFierce

 @DamianFierce: A federal court has tossed Fresenius' $83M Medicare fraud judgement. More  | Follow @DamianFierce

> FDA approves aortic-repair stent grafts. Article

> As it turns to medtech, Sony's credit rating gets lowered. Report

And Finally... Younger women suffering from chemotherapy-related menopause may get aid from talk therapy and exercise, a study found. Report

Suggested Articles

With generics at the gates, Novartis’ Gilenya secured a breath of fresh air—and protection for its blockbuster sales—with a federal injunction.

Akorn has been slammed with another FDA warning letter even as it is in the process of renegotiating its loans with lenders.

Horizon Therapeutics is preparing for the potential launch of inflammatory eye drug teprotumumab with team building.